Modified-vaccinia-virus-ankara (MVA) priming and fowlpox-virus booster elicit a stronger CD8+ T-cell response in mice against an HIV-1 epitope than does a DNA/poxvirus prime-booster approach

Biotechnology and Applied Biochemistry

Volumn 39, Issue 3, 2004, Pages 313-318

  Vázquez Blomquist, Dania ^a   Quintana, Diógenes ^a   Duarte, Carlos A ^a  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

DNA; ELISPOT; HIV; Poxvirus; Semliki Forest virus; Vaccine

Indexed keywords

DNA; ECOSYSTEMS; IMMUNOLOGY; POLYPEPTIDES; VIRUSES;

IMMUNOGENS; MODIFIED VACCINIA VIRUS ANKARA (MVA);

BIOCHEMISTRY;

EPITOPE; GAMMA INTERFERON; PRIMER DNA; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA VECTOR; FEMALE; FOWLPOX VIRUS; GENE INDUCTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REPLICON; SECRETORY CELL; SEMLIKI FOREST ALPHAVIRUS; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS RECOMBINANT;

ALPHAVIRUS; ANIMALIA; FOWLPOX VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; POXVIRIDAE; SEMLIKI FOREST VIRUS; VACCINIA VIRUS;

EID: 2942726162     PISSN: 08854513     EISSN: None     Source Type: Journal    
DOI: 10.1042/ba20030176     Document Type: Article

References (49)

1. McMichael, A. J. and Rowland-Jones, S. L. (2001) Nature (London) 410, 980-987
2. Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. et al. (1997) Nat. Med. 3, 205-211
3. Riviere, Y., McChesney, M. B., Porrot, F., Tanneau-Salvadori, F., Sansonetti, P. et al. (1995) AIDS Res. Hum. Retroviruses 11, 903-907
4. Rowland-Jones, S. L., Dong, T., Fowke, K. R., Kimani, J., Krausa, P., Newell, H., Blanchard, T., Ariyoshi, K., Oyugi, J., Ngugi, E. et al. (1998) J. Clin. Invest. 102, 1758-1765
5. Rowland-Jones, S. L., Dong, T., Dorrell, L., Ogg, G., Hansasuta, P., Krausa, P. et al. (1999) Immunol. Lett. 66, 9-14
6. Kent, S. J., Zhao, A., Best, S. J., Chandler, J. D., Boyle, D. B. and Ramshaw, I. A. (1998) J. Virol. 72, 10180-10188
7. Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A. et al. (1999) Science 283, 857-860
8. Robinson, H. L., Montefiori, D. C., Johnson, R. P., Manson, K. H., Kalish, M. L., Lifson, J. D., Rizvi, T. A., Lu, S., Hu, S. L., Mazzara, G. P. et al. (1999) Nat. Med. 5, 526-534
9. Robinson, H. L. (2002) Nat. Rev. Immunol. 2, 239-250
10. Boyle, D. B. and Heine, H. G. (1993) Immunol. Cell Biol. 71, 391-397
11. Antoine, G., Scheiflinger, F., Dorner, F. and Falkner, F. G. (1998) Virology 244, 365-396
12. Collings, A., Pitkanen, J., Strengell, M., Tahtinen, M., Lagerstedt, A., Hakkarainen, K., Ovod, V., Sutter, G., Ustav, M., Ustav, E. et al. (1999) Vaccine 18, 460-467
13. Cafaro, A., Titti, F., Fracasso, C., Maggiorella, M. T., Baroncelli, S., Caputo, A., Goletti, D., Borsetti, A., Pace, M., Fanales-Belasio, E. et al. (2001) Vaccine 19, 2862-2877
14. Boyer, J. D., Cohen, A. D., Vogt, S., Schumann, K., Nath, B., Ahn, L. et al. (2000) J. Infect. Dis. 181, 476-483
15. Smerdou, C. and Liljestrom, P. (1999) Curr. Opin. Mol. Ther. 1, 244-251
16. Perri, S., Driver, D. A., Gardner J. P., Sherrill, S., Belli, B. A., Dubensky, Jr, T. W. and Polo, J. M. (2000) J. Virol. 74, 9802-9807
17. Hanke, T., Samuel, R. V., Blanchard, T. J., Neumann, V. C., Allen, T. M., Boyson, J. E., Sharpe, S. A., Cook, N., Smith, G. L., Watkins, D. I. et al. (1999) J. Virol. 73, 7524-7532
18. Hanke, T., Blanchard, T. J., Schneider J., Hannan, C. M., Becker, M., Gilbert, S. C., Hill, A. V., Smith, G. L. and McMichael, A. (1998) Vaccine 16, 439-445
19. Schneider J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M., Sinden, R., Smith, G. L. and Hill, A. V. (1998) Nat. Med. 4, 397-402
20. Hanke, T. and McMichael, A. J. (2000) Nat. Med. 6, 951-955
21. Gonzalo, R. M., Rodriguez, D., Garcia-Sastre, A., Rodriguez, J. R., Palese, P. and Esteban, M. (1999) Vaccine 17, 887-892
22. Haglund, K., Leiner, I., Kerksiek, K., Buonocore, L., Pamer, E. and Rose, J. K. (2002) J. Virol. 76, 7506-7517
23. Gilbert, S. C., Schneider J., Hannan, C. M., Hu, J. T., Plebanski, M., Sinden, R. and Hill, A. V. (2002) Vaccine 20, 1039-1045
24. Hodge, J. W., McLaughlin, J. P., Kantor, J. A. and Schlom, J. (1997) Vaccine 15, 759-768
25. Aarts, W. M., Schlom, J. and Hodge, J. W. (2002) Cancer Res. 62, 5770-5777
26. Quintana, D., Gómez, C. E., Carpio, E., Iglesias, E. and Duarte, C. A. (2001) J. Biochem. Mol. Biol. Biophys. 5, 335-345
27. Vázquez, D., Green, P., Laidlaw, S. M., Skinner, M. A., Borrow, P. and Duarte, C. A. (2002) Viral Immunol. 15, 337-356
28. Gómez, C. E., Rodriguez, D., Rodriguez, J. R., Abaitua, F., Duarte, C. and Esteban, M. (2001) Vaccine 20, 961-971
29. Boulanger, D., Green, P., Smith, T., Czerny, C. P. and Skinner, M. A. (1998) J. Virol. 72, 170-179
30. Barouch, D. H., Santra, S., Schmitz, J. E., Kuroda, M. J., Fu, T. M., Wagner, W., Bilska, M., Craiu, A., Zheng, X. X., Krivulka, G. R. et al. (2000) Science 290, 486-492
31. Amara, R. R., Villinger F., Altman, J. D., Lydy, S. L., O'Neil, S. P., Staprans, S. I. et al. (2001) Science 292, 69-74
32. Barouch, D. H., Santra, S., Kuroda, M. J., Schmitz, J. E., Plishka, R., Buckler-White, A., Gaitan, A. E., Zin, R., Nam, J. H., Wyatt, L. S. et al. (2001) J. Virol. 75, 5151-5158
33. Marshall, J. L., Hoyer, R. J., Toomey, M. A., Faraguna, K., Chang, P., Richmond, E., Pedicano, J. E., Gehan, E., Peck, R. A., Arlen, P., Tsang, K. Y. and Schlom, J. (2000) J. Clin. Oncol. 18, 3964-3973: 11
34. Grosenbach, D. W., Barrientos, J. C., Schlom, J. and Hodge, J. W. (2001) Cancer Res. 61, 4497-4505
35. Irvine, K. R., Chamberlain, R. S., Shulman, E. P., Surman, D. R., Rosenberg, S. A. and Restifo, N. P. (1997) J. Natl. Cancer Inst. 89, 1595-1601
36. Carroll, M. W., Overwijk, W. W., Chamberlain, R. S., Rosenberg, S. A., Moss, B. and Restifo, N. P. (1997) Vaccine 15, 387-394
37. Li, S., Rodrigues, M., Rodriguez, D., Rodriguez, J. R., Esteban, M., Palese P., Nussenzweig, R. S. and Zavala, F. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 5214-5218
38. Murata, K., Garcia-Sastre, A., Tsuji, M., Rodrigues, M., Rodríguez, D., Rodriguez, J. R., Nussenzweig, R. S., Palese, P., Esteban, M. and Zavala, F. (1996) Cell. Immunol. 173, 96-107
39. Ourmanov, I., Bilska, M., Hirsch, V. M. and Montefiori, D. C. (2000) J. Virol. 74, 2960-2965
40. Seth, A., Ourmanov, I., Schmitz, J. E., Kuroda, M. J., Lifton, M. A., Nickerson, C. E., Wyatt, L., Carroll, M., Moss, B., Venzon, D. et al. (2000) J. Virol. 74, 2502-2509
41. Kent, S. J., Zhao, A., Dale, C. J., Land, S., Boyle, D. B. and Ramshaw, I. A. (2000) Vaccine 18, 2250-2256
42. Elahi, S. M., Bergeron, J., Nagy, E., Talbot, B. G., Harpin, S., Shen, S.-H. and Elazhary, Y. (1999) FEMS Microbiol. Lett. 171, 107-114
43. Laidlaw, S. M. and Skinner, M. A. (2004) J. Gen. Virol. 172, 3094-3100
44. Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Kutish, G. F. and Rock, D. L. (2000) J. Virol. 74, 3815-3831
45. Woodberry, T., Gardner, J., Elliott, S. L., Leyrer, S., Purdie, D. M., Chaplin, P. and Suhrbier, A. (2003) J. Immunol. 170, 2599-2604
46. Alcamí, A. and Smith, G. L. (1995) Immunol. Today 16, 474-478
47. Nilsson, C., Makitalo, B., Berglund, P., Bex, F., Liljestrom, P., Sutter, G., Erfle, V., ten Haaft, P., Heeney, J., Biberfeld, G. et al. (2001) Vaccine 19, 3526-3536
48. Hanke, T., Barnfield, C., Wee, E. G., Agren, L., Samuel, R. V., Larke, N. and Liljestrom, P. (2003) J. Gen. Virol. 84, 361-368
49. Hanke, T., Neumann, V. C., Blanchard, T. J., Sweeney, P., Hill, A. V. S., Smith, G. L. and McMichael, A. (1999) Vaccine 17, 589-596